The Combined Anti-Tumor Efficacy of Bioactive Hydroxyapatite Nanoparticles Loaded with Altretamine.

Alghazwani, Yahia; Venkatesan, Krishnaraju; Prabahar, Kousalya; El-Sherbiny, Mohamed; Elsherbiny, Nehal; Qushawy, Mona

Alghazwani, Yahia; Venkatesan, Krishnaraju; Prabahar, Kousalya; El-Sherbiny, Mohamed; Elsherbiny, Nehal; Qushawy, Mona.

Afiliação

Alghazwani Y; Department of Pharmacology, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.
Venkatesan K; Department of Pharmacology, College of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia.
Prabahar K; Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia.
El-Sherbiny M; Department of Basic Medical Sciences, College of Medicine, AlMaarefa University, Riyadh 13713, Saudi Arabia.
Elsherbiny N; Department of Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt.
Qushawy M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tabuk, Tabuk 71491, Saudi Arabia.

Pharmaceutics ; 15(1)2023 Jan 16.

Article em En | MEDLINE | ID: mdl-36678930

Palavras-chave

altretamine; cancer therapy; chemical precipitation method; hydroxyapatite nanoparticles; sustained delivery

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmaceutics Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Arábia Saudita País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google